In this issue
Broad Selective Efficacy of Recombinant Methioninase and Polyethylene Glycol-modified Recombinant Methioninase on Cancer Cells In Vitro
Jump to section
Related Articles
Cited By...
- Combination Methionine-methylation-axis Blockade: A Novel Approach to Target the Methionine Addiction of Cancer
- Oral Recombinant Methioninase Sensitizes a Bladder Cancer Orthotopic Xenograft Mouse Model to Low-dose Cisplatinum and Prevents Metastasis
- Adjuvant Oral Recombinant Methioninase Inhibits Lung Metastasis in a Surgical Breast-Cancer Orthotopic Syngeneic Model
- Oral dosing of Recombinant Methioninase Is Associated With a 70% Drop in PSA in a Patient With Bone-metastatic Prostate Cancer and 50% Reduction in Circulating Methionine in a High-stage Ovarian Cancer Patient
- Recombinant Methioninase Combined With Tumor-targeting Salmonella typhimurium A1-R Induced Regression in a PDOX Mouse Model of Doxorubicin-resistant Dedifferentiated Liposarcoma
- Evaluation of METase-pemetrexed-loaded PEG-PLGA nanoparticles modified with anti-CD133-scFV for treatment of gastric carcinoma
- Oncogenic PI3K promotes methionine dependency in breast cancer cells through the cystine-glutamate antiporter xCT
- Effective Metabolic Targeting of Human Osteosarcoma Cells In Vitro and in Orthotopic Nude-mouse Models with Recombinant Methioninase
- Molecular Pathways: Metabolic Control of Histone Methylation and Gene Expression in Cancer
- Pre-steady-state Kinetic and Structural Analysis of Interaction of Methionine {gamma}-Lyase from Citrobacter freundii with Inhibitors
- Therapeutic enzyme deimmunization by combinatorial T-cell epitope removal using neutral drift